Polaris AI Pharma Corp.

A041910

KR7041910001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-20 pm EDT			5-day change	1st Jan Change
7,880 ^KRW	-1.50%		-6.41%	+14.20%

May. 31	Polaris AI Pharma Corp. announced that it has received KRW 5.1536 billion in funding	CI
Mar. 27	Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. completed the acquisition of 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae.	CI

Korea Securities Finance Corporation acquired 4.06% stake in EstechPharma Co., Ltd..

October 10, 2013 at 12:00 am EDT

Korea Securities Finance Corporation acquired 4.06% stake in EstechPharma Co., Ltd. (KOSE:A041910) on October 10, 2013. Korea Securities Finance acquired 0.4 million shares of EstechPharma.

Korea Securities Finance Corporation completed the acquisition of 4.06% stake in EstechPharma Co., Ltd. (KOSE:A041910) on October 10, 2013.

Latest news about Polaris AI Pharma Corp.

Polaris AI Pharma Corp. announced that it has received KRW 5.1536 billion in funding	May. 30	CI
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. completed the acquisition of 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae.	Mar. 26	CI
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. agreed to acquire 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae for KRW 40 billion.	Feb. 28	CI
Polaris AI Pharma Corp. announced that it expects to receive KRW 5.1536 billion in funding	Feb. 01	CI
EstechPharma Co., Ltd.(KOSDAQ:A041910) dropped from S&P Global BMI Index	19-09-23	CI
Vivozon Inc. announced that it has received KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.	18-05-24	CI
Vivozon, Inc. announced that it expects to receive KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.	18-03-18	CI
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 12, 2016.	17-06-12	CI
EstechPharma Co., Ltd.'s Equity Buyback announced on December 12, 2016, has expired with 106,086 shares, representing 0.94% for KRW 1,054.08 million.	17-06-11	CI
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 12, 2016.	17-03-13	CI
EstechPharma Co., Ltd. authorizes a Buyback Plan.	16-12-11	CI
EstechPharma Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	16-12-11	CI
EstechPharma Co., Ltd.(KOSDAQ:A041910) added to S&P Global BMI Index	15-09-21	CI
Vivozon, Inc. announced that it has received KRW 2 billion in funding from EstechPharma Co., Ltd.	14-12-04	CI
Vivozon, Inc. announced that it expects to receive KRW 2 billion in funding from EstechPharma Co., Ltd.	14-12-01	CI
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 5, 2013.	13-12-30	CI
EstechPharma Co., Ltd.'s Equity Buyback announced on December 5, 2013 has closed with 110,619 shares for KRW 950.06 million.	13-12-29	CI
EstechPharma Co., Ltd. announces an Equity Buyback for 110,619 shares, for KRW 1,000 million.	13-12-04	CI
EstechPharma Co., Ltd. authorizes a Buyback Plan.	13-12-04	CI
Korea Securities Finance Corporation acquired 4.06% stake in EstechPharma Co., Ltd..	13-10-10	CI
Estechpharma Co. Ltd. announced that it has received KRW 4 billion in funding.	12-04-10	CI
Estechpharma Co. Ltd. announced that it expects to receive KRW 4 billion in funding.	12-04-06	CI

Chart Polaris AI Pharma Corp.

Duration

Period

More charts

Company Profile

Polaris AI Pharma Corp, formerly ESTECHPHARMA CO., LTD, is a Korea-based company engaged in the development and manufacture of pharmaceuticals. The Company is engaged in the manufacture and sale of peptic ulcer medicine, diabetes medicine, central nervous system medicine, antispasmodics, antipyretics, and painkillers. It has a research and development institute that develops active pharmaceutical ingredients. The company sells its products in domestic and international markets.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
POLARIS AI PHARMA CORP.	+14.20%	70.75M
ELI LILLY AND COMPANY	+51.63%	796B
NOVO NORDISK A/S	+41.51%	628B
JOHNSON & JOHNSON	-5.10%	358B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+9.95%	301B
ASTRAZENECA PLC	+17.66%	244B
ROCHE HOLDING AG	+3.39%	228B
NOVARTIS AG	+10.75%	214B
AMGEN INC.	+6.99%	165B

Other Pharmaceuticals

Polaris AI Pharma Corp.

Equities

A041910

KR7041910001

Pharmaceuticals

Korea Securities Finance Corporation acquired 4.06% stake in EstechPharma Co., Ltd..

Latest news about Polaris AI Pharma Corp.

Chart Polaris AI Pharma Corp.

Company Profile

Sector Other Pharmaceuticals